INTERNATIONAL PATENT: ANAVEX LIFE SCIENCES CORP. FILES APPLICATION FOR "METHODS OF USING SURROGATE BIOMARKERS IN SIGMA-1 RECEPTOR THERAPY"

GENEVA, June 12 -- ANAVEX LIFE SCIENCES CORP. (630 5th Avenue, 20th FloorNew York, New York 10111) filed a patent application (PCT/US2024/057864) for "METHODS OF USING SURROGATE BIOMARKERS IN SIGMA-1 RECEPTOR THERAPY" on Nov 27, 2024. With publication no. WO/2025/117826, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MISSLING, Christopher, U. (630 5th Avenue, 20th FloorNew York, New York 10111)

Abstract: The present disclosure provides precision medicine or personalized therapy of using a Sigma-1 receptor agonist in t...